Lu-177 NCA
non carrier added

Specifications
AVAILABILITY
HALF-LIFE
6.65 days
Available as:
⦁ Radiochemical
⦁ cGMP Radiopharmaceutical
6.65 days
Available as:
⦁ Radiochemical
⦁ cGMP Radiopharmaceutical
APPLICATION: 177Lu has virtually pervaded all areas of in vivo radionuclide therapy and may be poised to become a key therapeutic radionuclide of choice for targeted radionuclide therapy (TRT).
CHARACTERISTICS: Lutetium-177 is a beta emitter (β-) at 498keV (78.6%) and 177 keV (12.2%) decaying into stable Hafnium-177.
PROCESS DATA
GROWING ATTENTION